Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Agrylin granted priority review in Canada

March 7, 1997

Thrombin inhibitors disclosed by Astra

March 6, 1997

FDA advisory committee decision regarding Integrilin

March 4, 1997

Fibrinogen antagonists disclosed by Terumo

March 3, 1997

Abciximab and acute profound thrombocytopenia

Feb. 28, 1997

Antithrombotics from Fuji Yakuhin

Feb. 28, 1997

Japanese researchers describe anticoagulants

Feb. 27, 1997

Thrombin inhibitors from Merck & Co.

Feb. 26, 1997

Phase I study of pentosan polysulfate in cancer patients

Feb. 25, 1997

Centocor seeks expansion of ReoPro indications

Feb. 21, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...